Publications
caspofungin for invasive candidiasis at a tertiary care medical center. | caspofungin is emerging as first-line therapy for invasive candidiasis. data on the use of caspofungin for treatment for invasive candidiasis are limited to clinical trials and case reports. we report a single-center experience with 104 consecutive courses of caspofungin for the treatment of invasive candidiasis to evaluate a real-world performance of this drug. | 2006 | 17071169 |